Research Methodology – Biosimilars Market
At Straits Research, we adopt a rigorous 360° research approach that integrates both primary and secondary research methodologies. This ensures accuracy, reliability, and actionable insights for stakeholders. Our methodology for the Biosimilars Market comprises the following key stages:
Market Indicator & Macro-Factor Analysis
Our baseline thesis for the Biosimilars Market is developed by integrating key market indicators and macroeconomic variables. These include:
Factors considered while calculating market size and share
- Current and historical sales of biosimilars in various regions.
- Market penetration of different types of biosimilars.
- Comparative cost of originator biologics and biosimilars.
- The impact of patents and exclusivities on the biosimilars market.
- Regulatory environment and approvals for biosimilars in different markets.
- The role of third-party payers and reimbursement policies in biosimilars adoption.
- Research and development initiatives and pipeline products in the biosimilars space.
Key Market Indicators
- The number of approved biosimilars in significant markets like the US, EU, and Asia.
- Sales volume and value of major biosimilars.
- Market share of top biosimilars companies.
- Changes in healthcare policies affecting biosimilars.
- Growth rate of the biosimilars market annually.
- Projected biosimilars adoption rates based on various factors like pricing, availability, and physician adoption.
Growth Trends
- Increasing prevalence of chronic diseases driving the need for more cost-effective treatment options.
- Promising pipeline of biosimilars and expected approvals.
- Increasing healthcare expenditure and focus on affordable treatments.
- Growing awareness and acceptance of biosimilars in the medical community.
- Rising number of strategic collaborations for the development and distribution of biosimilars.
- Advanced regulatory framework fostering faster approval of biosimilars in various regions.
Secondary Research
Our secondary research forms the foundation of market understanding and scope definition. We collect and analyze information from multiple reliable sources to map the overall ecosystem of the Biosimilars Market. Key inputs include:
- Annual reports, investor presentations, SEC filings
- Company press releases and product launch announcements
- Public executive interviews and earnings calls
- Strategy briefings and M&A updates
- Country-level industry associations and trade bodies
- Government dossiers, policy frameworks, and official releases
- Whitepapers, working papers, and public R&D initiatives
- Relevant Associations for the Biosimilars Market
- Broker reports and financial analyst coverage
- Paid databases (Hoovers, Factiva, Refinitiv, Reuters, Statista, etc.)
- Import/export trade data and tariff databases
- Sector-specific journals, magazines, and news portals
- Global macroeconomic indicators and their cascading effect on the industry
- Demand–supply outlook and value chain analysis
- Consumer behaviour, adoption rates, and commercialization trends
Primary Research
To validate and enrich our secondary findings, we conduct extensive primary research with industry stakeholders across the value chain. This ensures we capture both qualitative insights and quantitative validation. Our primary research includes:
- Key Opinion Leader (KOL) Engagements
- Structured interviews with executives, product managers, and domain experts
- Paid and barter-based interviews across manufacturers, distributors, and end-users
- Discussions with stakeholders to validate demand-supply gaps
- Group discussions on emerging technologies, regulatory shifts, and adoption barriers
- Cross-verification of market sizing and forecasts with industry insiders
- Capturing business perspectives on growth opportunities and restraints
Data Triangulation & Forecasting
The final step of our research involves data triangulation ensuring accuracy through cross-verification of:
- Demand-side analysis (consumption patterns, adoption trends, customer spending)
- Supply-side analysis (production, capacity, distribution, and market availability)
- Macroeconomic & microeconomic impact factors
- Time-series analysis
- Regression and correlation studies
- Baseline modeling
- Expert validation at each stage
Outcome
The outcome is a comprehensive and validated market model that captures:
- Market sizing (historical, current, forecast)
- Growth drivers and restraints
- Opportunity mapping and investment hotspots
- Competitive positioning and strategic insights
Available for purchase with detailed segment data, forecasts, and regional insights.
Get This ReportOur Clients:
